CSTL
Castle Biosciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website castlebiosciences.com
- Employees(FY) 587
- ISIN US14843C1053
Performance
-3.98%
1W
+12.77%
1M
+24.17%
3M
+39.9%
6M
+54.26%
YTD
+85.36%
1Y
Profile
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary 35-GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.
Technical Analysis of CSTL 2024-11-08
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-08 07:00
- 2024-11-07 18:00
- 2024-11-07 12:00
- 2024-11-07 07:52
Castle boasts melanoma test’s capacity to reduce unnecessary testing(Medical Device Network)
- 2024-11-07 07:50
Castle boasts melanoma test’s capacity to reduce unnecessary testing(Clinical Trials Arena)
- 2024-11-07 07:00
- 2024-11-06 18:00
- 2024-11-06 07:00
- 2024-11-06 06:45
- 2024-11-06 06:31
Castle Biosciences Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
- 2024-11-06 06:25
- 2024-11-05 18:00
- 2024-11-05 16:40
- 2024-11-05 14:00
- 2024-11-04 17:50
- 2024-11-04 16:05
Castle Biosciences Reports Third Quarter 2024 Results(Business Wire)
- 2024-11-04 03:05
Castle Biosciences Reports Third Quarter 2024 Results(Businesswire)
- 2024-11-01 09:15
- 2024-10-31 21:05
- 2024-10-29 16:30
- 2024-10-29 10:01
- 2024-10-29 04:30
- 2024-10-28 07:00
- 2024-10-27 19:00
- 2024-10-23 08:50
- 2024-10-22 12:00
- 2024-10-21 03:43
- 2024-10-20 05:00
- 2024-10-19 17:00
- 2024-10-16 07:00
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.